Integrative transcriptomic meta-analysis reveals conserved transcriptional signatures and predictive biomarkers for
Tingting Li1, Huanqing Liu2, Qian Lei3
1Drug Clinical Trial Institution Office, Xi'an Chest Hospital, Xi'an, Shaanxi, China.
Background:
Tuberculosis (TB) caused 1.23 million deaths in 2024, with accurate diagnosis hampered by population heterogeneity and limited biomarker generalizability. We developed an integrative framework combining multi-cohort transcriptomics and machine learning to identify host-derived transcriptional signatures of active TB.
Methods:
Five transcriptomic datasets (GSE83456, GSE107995, GSE158802, GSE19435, GSE25534) comprising 529 samples were analyzed. After standardized preprocessing, we performed differential expression analysis, inverse variance-weighted meta-analysis, and single-sample gene set enrichment analysis (ssGSEA) for three KEGG pathways. Machine learning classifiers were developed using logistic regression with SHapley Additive exPlanations (SHAP)-based interpretability.
Results:
Meta-analysis identified 108 core differentially expressed genes (80 upregulated, 28 downregulated) conserved across all cohorts. Upregulated genes showed significant enrichment in interferon signaling, antigen presentation, and chemokine activity. Pathway analysis revealed modest downregulation in NF-κB signaling (fold-change: -0.023, p = 0.02), antigen presentation (fold-change: -0.026, p = 0.08), tuberculosis pathway (fold-change: -0.023, p = 0.05). Machine learning classifiers achieved excellent discrimination with cross-validated AUCs of 0.85-0.94 (mean: 0.89 ± 0.04), maintaining balanced sensitivity (82-91%) and specificity (85-93%). SHAP analysis identified interferon-stimulated genes (STAT1, IFITM1), chemokine receptors (CXCL10, CXCL9), and MHC class II molecules (HLA-DRA) as top predictive features, underscoring the biological relevance of the human host response to Mycobacterium tuberculosis.
Conclusion:
Our integrative framework identifies a conserved 347-gene transcriptional signature and three key immune pathways that transcend population and technical heterogeneity. The high diagnostic accuracy and biologically interpretable feature sets provide validated biomarkers for TB diagnosis and support clinical translation toward precision medicine approaches in global TB control.
Clinical Trial Registration:
https://www.chictr.org.cn/, identifier ChiCTR2300074328.
Related Concept Videos
01:26Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
01:30General Transcription Factors
01:29Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
01:28Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
01:28Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
01:31Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories: